donor memory t cells that have been depleted of cd62l+
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT03836690)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06034535 | Phase 2 | Sep 1, 2023 | Hong Kong Children's Hospital |
| NCT03836690 | Phase 1 | Sep 30, 2019 | Medical Research Council, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hong Kong Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Medical Research Council | Government | 1 | 0 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1